Europeiska unionen - svenska - EMA (European Medicines Agency)

accord healthcare s.l.u. - abirateronacetat - prostatiska neoplasmer - endokrin terapi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Europeiska unionen - svenska - EMA (European Medicines Agency)

mylan ireland limited - abirateronacetat - prostatiska neoplasmer - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Europeiska unionen - svenska - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateronacetat - prostatiska neoplasmer - endokrin terapi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Europeiska unionen - svenska - EMA (European Medicines Agency)

alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - andra nervsystemet droger - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

bayer animal health gmbh - flumetrin - bikupestrip - 275 mg - flumetrin 275 mg aktiv substans; propylenglykoldikaprylokaprat hjälpämne - bi

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

nod apiary ireland limited - myrsyra - bikupestrip - 68,2 g - sackaros, flytande hjälpämne; myrsyra 68,2 g aktiv substans - bi

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

vita bee health limited - tymol - gel - 12,5 g - tymol 12,5 g aktiv substans - tymol - bi

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

vita bee health limited - tymol - bikupegel - 12,5 g/dos - tymol 12,5 g aktiv substans - bi

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

veto-pharma - amitraz - bikupestrip - 500 mg - amitraz 500 mg aktiv substans - bi

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

sandoz a/s - dasatinib (vattenfri) - filmdragerad tablett - 20 mg - dasatinib (vattenfri) 20 mg aktiv substans; natriumlaurilsulfat hjälpämne; laktosmonohydrat hjälpämne